T1	PROC 46 91	Evaluación de la seguridad y la tolerabilidad
T2	PROC 96 115	recambio plasmático
#1	AnnotatorNotes T2	C0032113; Plasma Exchange; Therapeutic or Preventive Procedure
T3	LIVB 119 128	pacientes
#2	AnnotatorNotes T3	C0030705; Patients; Patient or Disabled Group
T4	DISO 133 155	síndrome post-COVID-19
T5	DISO 157 160	SPC
T6	PROC 181 209	recambio plasmático simulado
T7	PROC 211 218	placebo
T8	PROC 243 262	Recambio plasmático
#3	AnnotatorNotes T8	C0032113; Plasma Exchange; Therapeutic or Preventive Procedure
T9	PROC 268 279	tratamiento
#4	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	LIVB 285 294	pacientes
#5	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 299 321	Síndrome post-COVID-19
T12	PROC 323 364	Estudio piloto aleatorizado y doble ciego
T13	DISO 388 405	Covid Persistente
T14	DISO 407 429	Síndrome post-COVID-19
T15	DISO 456 478	Síndrome post-COVID-19
T16	LIVB 508 541	Individuos masculinos o femeninos
T17	Age 545 558	18 años o más
T18	DISO 576 607	infección previa por SARS-CoV-2
T19	Duration 608 624	al menos 90 días
T20	PROC 661 691	prueba SARS-CoV-2 nasofaríngea
T21	PROC 693 718	Polymerase chain reaction
T22	PROC 720 723	PCR
#6	AnnotatorNotes T22	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique | C0201657; C-reactive protein measurement; Laboratory Procedure
T23	PROC 777 810	test de antígenos rápido COVID-19
T24	PROC 812 815	TAR
#7	AnnotatorNotes T24	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T25	PROC 824 847	serología de SARS-CoV-2
T26	PROC 860 891	vacunación contra el SARS-CoV-2
#8	AnnotatorNotes T26	C5203672; SARS-CoV-2 vaccination; Therapeutic or Preventive Procedure
T27	PROC 898 934	Serología SARS-CoV-2 antiproteína N.
T28	DISO 939 954	Síntomas de SPC
T29	Duration 966 973	90 días
T30	DISO 980 989	infección
#9	AnnotatorNotes T30	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T31	Duration 1002 1018	al menos 2 meses
T32	Neg_cue 1021 1023	no
T33	Negated 1024 1041	pueden explicarse
T34	Negated 1049 1072	diagnóstico alternativo
T35	Neg_cue 1077 1079	No
T36	Negated 1080 1094	puede realizar
T37	DISO 1146 1154	síntomas
#10	AnnotatorNotes T37	C1457887; Symptoms; Sign or Symptom
T38	DISO 1160 1165	dolor
#11	AnnotatorNotes T38	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T39	DISO 1167 1176	depresión
#12	AnnotatorNotes T39	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction | C0344315; Depressed mood; Mental or Behavioral Dysfunction
T40	DISO 1179 1187	ansiedad
#13	AnnotatorNotes T40	C0003467; Anxiety; Mental or Behavioral Dysfunction
T41	PROC 1223 1276	escala de estado funcional de pacientes post-COVID-19
T42	PROC 1318 1348	canalización venosa periférica
T43	LIVB 1356 1378	mujeres en edad fértil
T44	Age 1367 1378	edad fértil
T45	PROC 1416 1437	método anticonceptivo
#14	AnnotatorNotes T45	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T46	CHEM 1469 1495	anticonceptivos hormonales
T47	DEVI 1497 1521	dispositivo intrauterino
#15	AnnotatorNotes T47	C0021900; Intrauterine Devices; Medical Device
T48	DEVI 1523 1526	DIU
#16	AnnotatorNotes T48	C0021900; Intrauterine Devices; Medical Device
T49	DISO 1531 1552	esterilidad anatómica
T50	PROC 1617 1626	protocolo
#17	AnnotatorNotes T50	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T51	PROC 1645 1656	seguimiento
#18	AnnotatorNotes T51	C0420316; Other follow-up; Health Care Activity
T52	PHYS 1702 1713	Comprensión
#19	AnnotatorNotes T52	C0162340; Comprehension; Mental Process
T53	PROC 1738 1762	consentimiento informado
#20	AnnotatorNotes T53	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T54	DISO 1793 1817	Infección por SARS-CoV-2
#21	AnnotatorNotes T54	C5203670; COVID19 (disease); Disease or Syndrome
T55	PROC 1818 1831	diagnosticada
#22	AnnotatorNotes T55	C0011900; Diagnosis; Diagnostic Procedure
T56	Duration 1840 1862	los 90 días anteriores
T57	CHEM 1883 1910	vacuna contra el SARS-CoV-2
T58	Duration 1919 1941	los 30 días anteriores
T59	Neg_cue 1946 1948	No
T60	Negated 1953 1965	limitaciones
T61	LIVB 2001 2007	sujeto
#23	AnnotatorNotes T61	C0681850; Study Subject; Group
T62	PROC 2097 2118	escala funcional PCFS
T63	Dose 2157 2163	250 ml
T64	Route 2175 2186	intravenoso
T65	DISO 2223 2259	insuficiencia cardíaca descompensada
T66	DISO 2262 2308	insuficiencia renal con sobrecarga de líquidos
#24	AnnotatorNotes T66	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T67	LIVB 2327 2372	Mujeres embarazadas o en periodo de lactancia
T68	PROC 2404 2429	plasmaféresis terapéutica
T69	Contraindicated 2404 2429	plasmaféresis terapéutica
T70	Neg_cue 2431 2433	No
T71	Negated 2455 2480	catéter venoso periférico
#25	AnnotatorNotes T71	C2985513; Peripheral Venous Catheter; Medical Device
T72	DISO 2491 2517	inestabilidad hemodinámica
T73	DISO 2520 2530	septicemia
#26	AnnotatorNotes T73	C0036690; Septicemia; Disease or Syndrome | C0243026; Sepsis; Disease or Syndrome
T74	DISO 2532 2539	alergia
#27	AnnotatorNotes T74	C0020517; Hypersensitivity; Pathologic Function
T75	CHEM 2552 2575	plasma fresco congelado
T76	CHEM 2578 2585	coloide
#28	AnnotatorNotes T76	C0009361; Colloids; Biomedical or Dental Material
T77	CHEM 2588 2596	albúmina
#29	AnnotatorNotes T77	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T78	DISO 2611 2618	alergia
#30	AnnotatorNotes T78	C0020517; Hypersensitivity; Pathologic Function
T79	CHEM 2633 2641	heparina
#31	AnnotatorNotes T79	C0019134; heparin; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T80	PROC 2646 2668	Ingresos hospitalarios
#32	AnnotatorNotes T80	C0184666; Hospital admission; Health Care Activity
T81	Date 2669 2677	actuales
T82	PROC 2721 2744	seguimiento del estudio
#33	AnnotatorNotes T82	C0420316; Other follow-up; Health Care Activity
T83	PROC 2776 2800	consentimiento informado
#34	AnnotatorNotes T83	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T84	LIVB 2864 2876	investigador
#35	AnnotatorNotes T84	C0035173; Research Personnel; Professional or Occupational Group
T85	Date 2895 2901	actual
T86	PROC 2950 2964	ensayo clínico
#36	AnnotatorNotes T86	C0008976; Clinical Trials; Research Activity
T87	Date 2971 2980	el día 90
T88	PROC 2984 2995	seguimiento
#37	AnnotatorNotes T88	C0420316; Other follow-up; Health Care Activity
T89	PROC 728 764	Transcription-Mediated Amplification
T90	PROC 766 769	TMA
T91	PROC 1278 1282	PCFS
T92	PROC 1456 1467	abstinencia
T93	Negated 2434 2448	disponibilidad
T94	Neg_cue 2749 2760	Incapacidad
T95	Spec_cue 2904 2917	planteamiento
T96	Speculated 2921 2931	participar
T97	Form 2167 2174	líquido
T98	DEVI 2455 2480	catéter venoso periférico
T99	Negated 2776 2800	consentimiento informado
T100	Negated 2807 2845	cumplir con los requisitos del estudio
T101	PROC 1049 1072	diagnóstico alternativo
T102	Quantifier_or_Qualifier 394 405	Persistente
T103	CONC 1031 1041	explicarse
T104	CONC 1049 1060	diagnóstico
T105	Observation 1080 1125	puede realizar todas las tareas / actividades
T106	Result_or_Value 1204 1216	grados 3 o 4
T107	Quantifier_or_Qualifier 1438 1454	altamente eficaz
T108	Observation 1586 1612	cumplir con los requisitos
T109	Observation 1702 1713	Comprensión
T110	Observation 1716 1725	capacidad
T111	Quantifier_or_Qualifier 1867 1879	Última dosis
T112	Quantifier_or_Qualifier 1966 1980	significativas
T113	Result_or_Value 2075 2090	grados 0, 1 o 2
T114	CONC 2097 2118	escala funcional PCFS
T115	Quantifier_or_Qualifier 2201 2211	peligrosos
T116	Observation 2286 2308	sobrecarga de líquidos
T117	Quantifier_or_Qualifier 2481 2489	adecuado
T118	Quantifier_or_Qualifier 2680 2689	previstos
T119	Observation 2807 2833	cumplir con los requisitos
T120	Observation 2881 2894	Participación
T121	Observation 2918 2920	de
T122	Observation 2921 2964	participar en cualquier otro ensayo clínico
T123	Patient 119 128	pacientes
T124	Patient 285 294	pacientes
T125	Patient 507 541		Individuos masculinos o femeninos
T126	History_of 576 585	infección
T127	History_of 593 607	por SARS-CoV-2
T128	Patient 1253 1262	pacientes
T129	Patient 1356 1378	mujeres en edad fértil
T130	History_of 1883 1889	vacuna
T131	Patient 2001 2007	sujeto
T132	Patient 2327 2372	Mujeres embarazadas o en periodo de lactancia
T133	History_of 2532 2539	alergia
T134	History_of 2611 2618	alergia
T135	Future 2646 2668	Ingresos hospitalarios
T136	Other 2864 2876	investigador
T137	Future 2921 2931	participar
T138	Future 2950 2964	ensayo clínico
